| Literature DB >> 32116794 |
Anna Kuntze1, Ole Goetsch1, Benedikt Fels2, Karolina Najder1, Andreas Unger1, Marianne Wilhelmi1, Sarah Sargin1, Sandra Schimmelpfennig1, Ilka Neumann1, Albrecht Schwab1, Zoltan Pethő1.
Abstract
Pancreatic ductal adenocarcinoma (Entities:
Keywords: cell migration; fibrosis; pH homeostasis; pancreatic cancer; pancreatic stellate cells; piezo1
Year: 2020 PMID: 32116794 PMCID: PMC7033545 DOI: 10.3389/fphys.2020.00089
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Blebbistatin scoring system. Scores ranging from 1 to 3 were given for individual pancreatic stellate cells (PSCs) based on three criteria (membrane concavities, stress fibers, and dendritic-like processes), which are characteristic morphological alterations observed in blebbistatin-treated PSCs. The representative images show αSMA immunocytochemistry of PSCs. The membrane concavities are highlighted with orange arrows.
Figure 2Piezo1 is functionally expressed in PCSs. (A) Representative Western blots of Piezo1 compared to GAPDH in PSCs, wild-type HEK293 cells (HEKWT) and HEK293 cells transfected with control plasmid (HEKGFP+) or Piezo1 (HEKPiezo1+) (N = 3). (B) Piezo1 immunocytochemistry of non-permeabilized PSCs shows homogeneous channel distribution in the cell membrane. (C) Representative Mn2+-induced Fura-2 quench traces of PSCs in the presence of 20 μM Yoda1 or equivalent amount of the solvent, 0.075% DMSO (Ctrl). The scatter plots on the right show the respective values of Mn2+ quench slopes, the Mn2+ entry rate. The black lines indicate mean ± SEM. (n = 72, N = 3 for each condition). (D) Representative GFP image of Piezo1-transfected HEK293 cells. Only GFP+ cells were evaluated in the Mn2+ quench experiments. The bar chart on the right shows the evaluation of GFP signal intensities after control plasmid (HEKGFP+) and Piezo1 (HEKPiezo1+) transfection compared to untransfected HEK293 cells with intensities <100. (E) HEK293 cell derived Mn2+ quench traces in the presence of the solvent 0.025% DMSO or 5 μM Yoda1 in case of HEKGFP+ (n = 82; n = 50, respectively, N = 3) or HEKPiezo1+ cells (n = 106; n = 60, respectively, N = 3). The scatter plots indicate Mn2+ entry rates of individual cells for each condition. The black lines indicate mean ± SEM. *p < 0.05.
Figure 3Yoda1-elicited responses in PSCs. (A) Trajectories of individual PSCs migrating on a 2D substrate in the absence or presence of 5 μM Yoda1. Trajectories are normalized to common starting points. The radii of the orange circles show the mean translocation in both cases. (B) Mean velocity and translocation, respectively, were calculated from the trajectories for a 6-h time span. Five micrometer and 15 μM Yoda1 treatments were compared to 0.075% DMSO (Ctrl), whereas 50 μM Yoda was compared to 0.25% DMSO (Ctrl high DMSO). (C) Phase contrast images of spheroids at time points 0 and 24 h show matrix invasion of the vehicle-treated (Ctrl) and 20 μM Yoda1-treated spheroids. The left plot shows spheroid area after 24 h normalized to the initial area at 0 h (Ctrl: n = 54, N = 8; Yoda1 n = 51, N = 8). The right plot indicates the number of cells detached from the spheroids (Ctrl: n = 45, N = 8; Yoda1 n = 39, N = 8). (D) Phase contrast image of 50 ng/ml PDGF-treated PSC spheroid boundary shows microbead traction toward the spheroid (pink lines, see also Video 1). Black lines on the scatter plot show mean ± SEM. *p < 0.05.
Figure 4pH-dependent modulation of Piezo1 function. (A) Evaluation of intracellular acidification after superfusion of HEK293Piezo1+ cells with pH 6.6 Ringer's solution (n = 68) or 30 mM propionate (PA; n = 64). Error bars represent SEM. (B,C) Representative Mn2+ quench traces upon superfusion of HEK293Piezo1+ cells with solvent (B) or 5 μM Yoda1 (C) with pH 7.4 or pH 6.6 Ringer's solution, sodium propionate (PA) or pH 6.6 Ringer's solution + propionate (PA). The bar graphs on the right show the statistical evaluation for each condition, where ↓ indicates acidification of the pHe or pHi. Column charts show mean ± SEM. *p < 0.05 (D) The scatter plot shows Mn2+ entry rates after acidification of the intracellular and/or extracellular space in control-transfected or Piezo1-transfected HEK293 cells without or with the co-superfusion with 5 μM Yoda1. The number of evaluated cells is indicated above each group. The dashed line indicates the mean Mn2+ entry rate of all control transfected HEK293 cells for better comparability. The intracellular (circle) and extracellular (rectangle) pH environment is color-coded below the groups, with blue meaning physiological pH (pHi = 7.25, pHe = 7.4), whereas red means acidic pH (pHi = 6.7, pHe = 6.6). Black lines show mean ± SEM.
Figure 5Blebbistatin disrupts the cytoskeleton and impairs Piezo1 function in PSCs. (A) Representative Mn2+ quench traces of control and 20 μM Yoda1 treated PSCs after pretreatment with 5 μM blebbistatin (+Blebbi) for 15 min. For comparison, a trace of Yoda-1 induced Mn2+ quench without blebbistatin pretreatment is shown in gray. The scatter plots show the Mn2+ entry rate (n = 133 and n = 175, respectively, N = 3). *p < 0.05. (B) Piezo1 immunofluorescence after pretreatment with 5 μM blebbistatin. Scatter plot depicts Piezo1 channel densities (n = 300 regions of 30 cells, N = 3 experiments). (C) Representative immunofluorescence against αSMA (green). Images show PSCs treated with 0.1% DMSO (Ctrl) or blebbistatin (Blebbi). The Blebbistatin score graph depicts the quantification of the cytoskeletal and morphological alterations, detailed in Figure 1. Column charts show mean ± SEM (n = 30 cells, N = 3).
Figure 6Yoda-1 modifies myosin light chain phosphorylation (P-MYL9) in PSCs. (A) Immunocytochemistry images of PSCs treated with vehicle (0.2% DMSO; Ctrl) or 5 μM Yoda1 for 1 h, indicating P-MYL9 (red) and NMIIA (green) of different cells. Scatter plot indicates the total cellular fluorescence intensity of P-MYL9 normalized to NMIIA fluorescence (n = 90, N = 3). (B) Representative Western blots of P-MYL2 and MYL-2, compared to GAPDH, respectively, without or with 5 μM Yoda1 treatment. Scatter plot shows the results for individual PSC lysates (Ctrl: n = 5, N = 5; Yoda1 n = 4, N = 4). *p < 0.05.
Figure 7Yoda1 impairs PSC viability in spheroids in acidic conditions. (A) Representative Mn2+ quench traces of PSCs upon acidification with 30 mM sodium propionate (PA) in pH 6.6 or pH 7.4 Ringer's solution. Scatter plots show statistical evaluation in each condition (n = 48, n = 57, n = 45, n = 46, respectively, N = 5). (B) Microbead traction toward the spheroid in the presence of vehicle (0.1% DMSO, Ctrl) or 20 μM Yoda1 in pH 6.6 or pH 7.4 buffered medium supplemented with 50 ng/ml PDGF (n = 48, n = 57, n = 45, n = 46, respectively, N = 5). (C) Total area of dissociated acellular space within a spheroid section compared to whole cross-sectional spheroid area (n = 58, n = 42, n = 35, n = 52 sections, respectively, of spheroids from N = 3 mice). (D) Representative spheroid sections stained with hematoxylin and eosin. (E,F) Scatter plots indicate viability of PSC spheroids in conditions detailed above using MTT reduction assay and Annexin V staining, respectively (n = 6, N = 3). Data points were normalized to pH 7.4 buffered medium supplemented with 50 ng/ml PDGF and vehicle (0.1% DMSO). *p < 0.05.